Product Images Advair Diskus

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 17 images provide visual information about the product associated with Advair Diskus NDC 33261-874 by Aidarex Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1. Cumulative Incidence of Asthma-Related Deaths in the 28-Week Salmeterol Multi-center Asthma Research Trial (SMART), by Duration of Treatment - advair diskus for glaxosmithkline 1

Figure 1. Cumulative Incidence of Asthma-Related Deaths in the 28-Week Salmeterol Multi-center Asthma Research Trial (SMART), by Duration of Treatment - advair diskus for glaxosmithkline 1

Figure 1 - advair diskus for glaxosmithkline 10

Figure 1 - advair diskus for glaxosmithkline 10

Figure 2 - advair diskus for glaxosmithkline 11

Figure 2 - advair diskus for glaxosmithkline 11

Figure 3 - advair diskus for glaxosmithkline 12

Figure 3 - advair diskus for glaxosmithkline 12

Figure 4 - advair diskus for glaxosmithkline 13

Figure 4 - advair diskus for glaxosmithkline 13

Figure 5 - advair diskus for glaxosmithkline 14

Figure 5 - advair diskus for glaxosmithkline 14

Figure 6 - advair diskus for glaxosmithkline 15

Figure 6 - advair diskus for glaxosmithkline 15

IMAGE LABEL - advair diskus for glaxosmithkline 16

IMAGE LABEL - advair diskus for glaxosmithkline 16

This is a description of a medication called Advair Diskus, which is a generic version of the drug with the same name. The medication is distributed by Aidarex Pharmaceuticals LLC and contains Fluticasone Propionate with a strength of 100mcg, and Salmeterol with a strength of 50mcg. The medication is available in the form of inhalation powder, intended for use twice daily. The medication is manufactured by GlaxoSmithKline in Triangle Park, North Carolina. The description includes NDC numbers for different dosages and quantities of the medication.*

IMAGE LABEL - advair diskus for glaxosmithkline 17

IMAGE LABEL - advair diskus for glaxosmithkline 17

This is a description of a medication named "ADVAIR DISKUS". The medication is an inhalation powder used twice a day, containing Fluticasone Propionate and Salmeterol. The dosage is 250/50mcg with 60 doses in a package. The manufacturer is GlaxoSmithKline located in Triangle Park, NC 27709, and the product is distributed by AIDAREX PHARMACEUTICALS LLC. The package has NDC code: 33261-0874-01, and the prescription number is 1001024529.*

fluticasone propionate chemical structure - advair diskus for glaxosmithkline 2

fluticasone propionate chemical structure - advair diskus for glaxosmithkline 2

salmeterol xinafoate chemical structure - advair diskus for glaxosmithkline 3

salmeterol xinafoate chemical structure - advair diskus for glaxosmithkline 3

Figure 2. Mean Percent Change From Baseline in FEV1 in Patients With Asthma Previously Treated With Either Inhaled Corticosteroids or Salmeterol (Study 1) - advair diskus for glaxosmithkline 4

Figure 2. Mean Percent Change From Baseline in FEV1 in Patients With Asthma Previously Treated With Either Inhaled Corticosteroids or Salmeterol (Study 1) - advair diskus for glaxosmithkline 4

Figure 3. Percent Change in Serial 12-hour FEV1 in Patients With Asthma Previously Using Either Inhaled Corticosteroids or Salmeterol (Study 1) - advair diskus for glaxosmithkline 5

Figure 3. Percent Change in Serial 12-hour FEV1 in Patients With Asthma Previously Using Either Inhaled Corticosteroids or Salmeterol (Study 1) - advair diskus for glaxosmithkline 5

Figure 4. Percent Change in Serial 12-hour FEV1 in Patients With Asthma Previously Using Either Inhaled Corticosteroids or Salmeterol (Study 1) - advair diskus for glaxosmithkline 6

Figure 4. Percent Change in Serial 12-hour FEV1 in Patients With Asthma Previously Using Either Inhaled Corticosteroids or Salmeterol (Study 1) - advair diskus for glaxosmithkline 6

Figure 5. Predose FEV1: Mean Percent Change From Baseline in Patients With Chronic Obstructive Pulmonary Disease - advair diskus for glaxosmithkline 7

Figure 5. Predose FEV1: Mean Percent Change From Baseline in Patients With Chronic Obstructive Pulmonary Disease - advair diskus for glaxosmithkline 7

Figure 6. Two-Hour Postdose FEV1: Mean Percent Changes From Baseline Over Time in Patients With Chronic Obstructive Pulmonary Disease - advair diskus for glaxosmithkline 8

Figure 6. Two-Hour Postdose FEV1: Mean Percent Changes From Baseline Over Time in Patients With Chronic Obstructive Pulmonary Disease - advair diskus for glaxosmithkline 8

This appears to be a pharmaceutical document showing the effectiveness of different medications in treating a respiratory condition. The medications are Adavair Diskus 250/50, Fluticasone Propionate 250mcg daily, and Placebo. The document includes baseline FEV (forced expiratory volume) for each medication and some numerical data, but it is not clear what the data represents.*

Diskus parts - advair diskus for glaxosmithkline 9

Diskus parts - advair diskus for glaxosmithkline 9

This text refers to the various parts of a device, probably a medical one, that includes a lever, a mouthpiece, a dose indicator, a thumb grip, and an outer case.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.